Stock listing
BOATS:QSI Quantum-Si Incorporated Stock
US listing (BOATS) of Quantum-Si Incorporated · home listing NASDAQ:QSI
Follow Quantum-Si Incorporated into a list and get an email when it puts out news.
Home listing price · NASDAQ:QSI
$0.909 USD -0.161 (-15.0%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:QSI
- Day range
- $0.892 – $1.040 USDNov 20, 2026
- Volume
- 7.80M sharesNov 20, 2026
- Market cap
- $180.8M USDAt the close on Nov 20, 2026 · price × 198.9M shares outstanding
- 52-week range
- $0.690 – $1.810 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $8.60M USDMedian day 5.36M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:QSI · Home | $0.909 USD | -0.161 (-15.0%) | 7,801,382 | $1.020 | $1.040 | $0.892 | $1.070 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:QSI · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.909 | -0.161 | -15.0% | $1.020 | $1.040 | $0.892 | 7,801,382 | |
| $1.070 | +0.060 | +5.9% | $1.145 | $1.210 | $1.050 | 10,474,160 | |
| $1.010 | -0.050 | -4.7% | $1.060 | $1.080 | $0.992 | 5,352,378 | |
| $1.060 | -0.090 | -7.8% | $1.100 | $1.110 | $1.040 | 5,312,296 | |
| $1.150 | -0.070 | -5.7% | $1.230 | $1.230 | $1.140 | 3,536,152 | |
| $1.220 | -0.050 | -3.9% | $1.173 | $1.250 | $1.160 | 5,467,821 | |
| $1.270 | -0.010 | -0.8% | $1.348 | $1.450 | $1.240 | 6,848,954 | |
| $1.280 | -0.090 | -6.6% | $1.330 | $1.390 | $1.235 | 5,450,664 | |
| $1.370 | +0.040 | +3.0% | $1.360 | $1.380 | $1.302 | 5,572,636 | |
| $1.330 | +0.160 | +13.7% | $1.180 | $1.450 | $1.180 | 8,203,148 | |
| $1.170 | -0.120 | -9.3% | $1.270 | $1.275 | $1.080 | 6,685,167 | |
| $1.290 | -0.010 | -0.8% | $1.310 | $1.330 | $1.210 | 6,305,474 | |
| $1.300 | +0.040 | +3.2% | $1.270 | $1.340 | $1.241 | 4,551,363 | |
| $1.260 | -0.200 | -13.7% | $1.490 | $1.500 | $1.230 | 8,091,403 | |
| $1.460 | -0.290 | -16.6% | $1.565 | $1.600 | $1.405 | 9,872,279 | |
| $1.750 | +0.030 | +1.7% | $1.681 | $1.810 | $1.660 | 8,495,392 | |
| $1.720 | +0.070 | +4.2% | $1.630 | $1.730 | $1.590 | 9,949,577 | |
| $1.650 | +0.190 | +13.0% | $1.500 | $1.750 | $1.495 | 16,461,938 | |
| $1.460 | +0.060 | +4.3% | $1.420 | $1.480 | $1.360 | 10,265,376 | |
| $1.400 | +0.250 | +21.7% | $1.155 | $1.420 | $1.150 | 11,414,800 | |
| $1.150 | -0.080 | -6.5% | $1.170 | $1.210 | $1.145 | 3,572,200 | |
| $1.230 | +0.070 | +6.0% | $1.160 | $1.230 | $1.160 | 3,422,700 | |
| $1.160 | +0.070 | +6.4% | $1.060 | $1.200 | $1.040 | 6,172,600 | |
| $1.090 | -0.030 | -2.7% | $1.145 | $1.150 | $1.010 | 8,714,000 | |
| $1.120 | -0.190 | -14.5% | $1.330 | $1.330 | $1.100 | 7,690,600 | |
| $1.310 | -0.080 | -5.8% | $1.350 | $1.390 | $1.240 | 9,269,400 | |
| $1.390 | -0.020 | -1.4% | $1.340 | $1.440 | $1.330 | 5,364,900 | |
| $1.410 | +0.050 | +3.7% | $1.345 | $1.460 | $1.310 | 6,239,600 | |
| $1.360 | -0.170 | -11.1% | $1.475 | $1.475 | $1.340 | 10,356,400 | |
| $1.530 | +0.310 | +25.4% | $1.260 | $1.660 | $1.258 | 40,903,900 | |
| $1.220 | -0.060 | -4.7% | $1.290 | $1.300 | $1.200 | 5,851,500 | |
| $1.280 | +0.060 | +4.9% | $1.170 | $1.310 | $1.090 | 8,037,000 | |
| $1.220 | -0.060 | -4.7% | $1.290 | $1.410 | $1.190 | 8,703,200 | |
| $1.280 | -0.270 | -17.4% | $1.525 | $1.530 | $1.260 | 19,185,000 | |
| $1.550 | +0.120 | +8.4% | $1.385 | $1.550 | $1.170 | 18,774,100 | |
| $1.430 | +0.360 | +33.6% | $1.200 | $1.480 | $1.150 | 33,063,400 | |
| $1.070 | +0.112 | +11.7% | $0.960 | $1.120 | $0.960 | 13,838,800 | |
| $0.958 | +0.163 | +20.5% | $0.805 | $1.030 | $0.805 | 23,007,100 | |
| $0.795 | -0.039 | -4.7% | $0.825 | $0.834 | $0.795 | 1,562,300 | |
| $0.834 | +0.049 | +6.2% | $0.794 | $0.840 | $0.776 | 2,593,500 | |
| $0.785 | +0.026 | +3.4% | $0.750 | $0.799 | $0.743 | 1,593,300 | |
| $0.759 | -0.026 | -3.3% | $0.790 | $0.805 | $0.752 | 1,476,500 | |
| $0.785 | +0.029 | +3.8% | $0.760 | $0.792 | $0.751 | 2,429,900 | |
| $0.756 | +0.011 | +1.5% | $0.759 | $0.766 | $0.750 | 1,122,800 | |
| $0.745 | -0.025 | -3.2% | $0.790 | $0.802 | $0.740 | 1,708,600 | |
| $0.770 | +0.040 | +5.5% | $0.750 | $0.796 | $0.750 | 2,823,600 | |
| $0.730 | +0.010 | +1.4% | $0.721 | $0.753 | $0.721 | 909,700 | |
| $0.720 | -0.005 | -0.7% | $0.720 | $0.741 | $0.720 | 1,164,700 | |
| $0.725 | -0.015 | -2.0% | $0.729 | $0.748 | $0.720 | 1,387,900 | |
| $0.740 | +0.001 | +0.1% | $0.739 | $0.755 | $0.739 | 1,069,100 | |
| $0.739 | -0.011 | -1.5% | $0.750 | $0.755 | $0.725 | 1,712,500 | |
| $0.750 | -0.010 | -1.3% | $0.760 | $0.775 | $0.746 | 1,441,900 | |
| $0.760 | -0.006 | -0.8% | $0.767 | $0.790 | $0.760 | 1,049,000 | |
| $0.766 | +0.005 | +0.7% | $0.760 | $0.774 | $0.760 | 897,300 | |
| $0.761 | 0.000 | 0.0% | $0.767 | $0.786 | $0.760 | 980,000 | |
| $0.761 | +0.004 | +0.5% | $0.759 | $0.785 | $0.750 | 1,615,600 | |
| $0.757 | -0.009 | -1.2% | $0.750 | $0.777 | $0.750 | 1,503,700 | |
| $0.766 | -0.014 | -1.8% | $0.779 | $0.780 | $0.763 | 1,133,200 | |
| $0.780 | -0.023 | -2.9% | $0.822 | $0.822 | $0.770 | 2,412,700 | |
| $0.803 | +0.012 | +1.5% | $0.791 | $0.834 | $0.790 | 1,373,600 | |
| $0.791 | -0.056 | -6.6% | $0.850 | $0.855 | $0.790 | 2,662,900 | |
| $0.847 | +0.078 | +10.1% | $0.789 | $0.859 | $0.782 | 4,366,300 | |
| $0.769 | -0.066 | -7.9% | $0.800 | $0.830 | $0.752 | 3,853,800 | |
| $0.835 | +0.055 | +7.1% | $0.785 | $0.931 | $0.780 | 7,825,100 | |
| $0.780 | +0.010 | +1.3% | $0.767 | $0.810 | $0.767 | 3,233,600 |
- Ticker
- BOATS:QSI
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Nov 18, 2026
Quantum-Si Achieves Historic Milestone in Protein Sequencing with Single-Molecule Detection of All 20 Amino Acids on Proteus™
Latest earnings call · Nov 5, 2026
Quantum-Si (NASDAQ:QSI) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Sep 29, 2026
World HUPO 2026
Conference · 21 slides
Latest news
Quantum-Si Achieves Historic Milestone in Protein Sequencing with Single-Molecule Detection of All 20 Amino Acids on Proteus™
Nov 18, 2026
Closed $1.07 (+5.9%) on Nov 18, 2026
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 13, 2026
Closed $1.06 (-7.8%) on Nov 16, 2026
Quantum-Si Reports Third Quarter 2026 Financial Results and Provides Business Update
Nov 5, 2026
Closed $1.33 (+13.7%) on Nov 6, 2026
Quantum-Si to Provide a Business Update and Report Third Quarter 2026 Financial Results on November 5, 2026
Oct 16, 2026
Closed $1.12 (-14.5%) on Oct 16, 2026
Quantum-Si Regains Compliance with Nasdaq Minimum Bid Price Requirement
Oct 15, 2026
Closed $1.31 (-5.8%) on Oct 15, 2026
Quantum-Si Demonstrates Detection of 19 Amino Acids in Proteus™ Development Program
Oct 8, 2026
Closed $1.53 (+25.4%) on Oct 9, 2026
Quantum-Si Presents Interim Proteus™ Data at World HUPO 2026 Demonstrating a Significant Step Change in Performance Compared to Platinum® Pro
Sep 28, 2026
Closed $0.958 (+20.5%) on Sep 29, 2026
Quantum-Si Announces Detection of 18 Amino Acids Using a Developmental Sequencing Kit on Proteus™
Sep 15, 2026
Closed $0.72 (-0.7%) on Sep 15, 2026
Quantum-Si Expands Proteus™ Roadshow with Additional U.S. and European Cities
Sep 9, 2026
Closed $0.75 (-1.3%) on Sep 9, 2026
Quantum-Si to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Aug 18, 2026
Closed $0.728 (-2.2%) on Aug 18, 2026
Quantum-Si Incorporated on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 28 in the last 12 months · 151 in all · newest Nov 18, 2026 · oldest 2021
- Calls
- 22 calls with a replay · 22 with a transcript · latest Nov 5, 2026
- Decks
- 14 decks · latest Sep 29, 2026
Where Quantum-Si Incorporated is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:QSI · Home listing | NASDAQ | United States | USD |
| BOATS:QSI · This page | BOATS | United States | USD |
Valuation
EV/sales 63.3× against a median of 3.8×: the highest of 11 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $80.11M USD
- P/E
- Loss
- EV/sales
- 63.3×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 1.1×
- Gross margin
- 34.9%
- Operating margin
- Revenue too small
- Net margin
- Revenue too small
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 3.19
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Quantum-Si Incorporated · NASDAQ:QSI | US$180.8M | US$80.11M | n/a | 63.3× | n/a | 1.1× | n/a | 0.0× | 3.19 |
| Shanghai Rendu Biotechnology Co., Ltd. Class A · SSE:688193 | US$216.7M | US$100.3M | 64.7× | 4.2× | n/a | 1.6× | 13.9% | 0.0× | n/a |
| Median Technologies · EURONEXT:ALMDT | US$214.8M | US$176.5M | n/a | 6.9× | n/a | n/a | −145.8% | n/a | n/a |
| Tomocube, Inc. · KRX:475960 | US$208.3M | US$187.2M | n/a | 16.6× | n/a | 7.4× | −16.1% | 0.0× | n/a |
| Guangzhou LBP Medicine Science & Technology Co., Ltd. Class A · SSE:688393 | US$195.9M | US$151.2M | n/a | 2.8× | n/a | 1.2× | −9.2% | 0.0× | n/a |
| Dishman Carbogen Amcis Ltd. · NSE:DCAL | US$195.5M | US$195.5M | 26.6× | 0.8× | 4.2× | 0.3× | 3.0% | 0.0× | n/a |
| Tarsons Products Limited · NSE:TARSONS | US$174.2M | US$174.2M | 146× | 3.7× | 13.5× | 2.5× | 2.5% | 0.0× | n/a |
| AVE Science & Technology Co., Ltd. Class A · SSE:688067 | US$170.2M | US$138.2M | 33.8× | 3.9× | n/a | 2.1× | 14.3% | 0.0× | n/a |
| Binex Co., Ltd · KRX:053030 | US$162.2M | US$182.2M | n/a | 1.6× | n/a | 1.4× | −18.6% | 0.4× | n/a |
| Boditech Med, Inc. · KRX:206640 | US$152.0M | US$120.9M | 7.9× | 0.9× | 4.4× | 0.8× | 14.8% | 0.0× | n/a |
| Genovis AB · OMXSTO:GENO | US$150.3M | US$142.9M | 74.9× | 10.8× | 41.7× | 5.0× | 15.1% | 0.3× | n/a |
| Median of the others | US$184.9M | US$162.7M | 49.2× | 3.8× | 9.0× | 1.6× | 2.8% | 0.0× |
Forecasts
2 strong buy · 1 hold · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.
- Price target
- 2.27 USD · Analysts' mean
- EPS, year to Dec 2026
- -0.40 · 1 analyst
- Revenue, year to Dec 2026
- 1.05M · 3 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Jeff Hawkins | President and Chief Executive Officer |
| Jeff Keyes | Chief Financial Officer |
| Beth Peralta | Vice President, Human Resources |
| Ryan Miranovich | Vice President, Legal |
Board
| Director | Role |
|---|---|
| Charles Kummeth | Chairman of the Board |
| Gloria Sheynkman | Chair, Scientific Advisory Board |
| Jonathan M. Rothberg | Chairman of the Board |
| Amir Jafri | Director |
| Brigid A. Makes | Director |
| Jack Kenny | Director |
| Kevin Rakin | Director |
| Paula Dowdy | Director |
| Ruth Fattori | Director |
| Scott Mendel | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Quantum-Si (NASDAQ:QSI) Q3 2026 Earnings Call | Thu, Nov 05, 2026 · 4:30 PM ET | Replay |
| Quantum-Si (NASDAQ:QSI) Q2 2026 Earnings Call | Thu, Aug 13, 2026 · 4:30 PM ET | Replay |
| Quantum-Si (NASDAQ:QSI) Q1 2026 Earnings Call | Thu, May 07, 2026 · 4:30 PM ET | Replay |
| Quantum-Si (NASDAQ:QSI) Q4 2025 Earnings Call | Tue, Mar 03, 2026 · 4:30 PM ET | Replay |
| Quantum-Si (NASDAQ:QSI) Q3 2025 Earnings Call | Wed, Nov 05, 2025 · 4:30 PM ET | Replay |
| Quantum-Si (NASDAQ:QSI) Q2 2025 Earnings Call | Tue, Aug 05, 2025 · 4:30 PM ET | Replay |
| Quantum-Si (NASDAQ:QSI) Q1 2025 Earnings Call | Thu, May 15, 2025 · 4:30 PM ET | Replay |
| Quantum-Si (NASDAQ:QSI) Q4 2024 Earnings Call | Mon, Mar 03, 2025 · 4:30 PM ET | Replay |
| Quantum-Si (NASDAQ:QSI) Q3 2024 Earnings Call | Tue, Nov 12, 2024 · 8:00 AM ET | Replay |
| Quantum-Si (NASDAQ:QSI) Q2 2024 Earnings Call | Wed, Aug 07, 2024 · 4:30 PM ET | Replay |
All 22 calls
| Call | When | Status |
|---|---|---|
| Quantum-Si (NASDAQ:QSI) Q1 2024 Earnings Call | Thu, May 09, 2024 · 4:30 PM ET | Replay |
| Quantum-Si (NASDAQ:QSI) Q4 2023 Earnings Call | Thu, Feb 29, 2024 · 4:30 PM ET | Replay |
| Quantum-Si (NASDAQ:QSI) Q3 2023 Earnings Call | Thu, Nov 09, 2023 · 4:30 PM ET | Replay |
| Quantum-Si (NASDAQ:QSI) Q2 2023 Earnings Call | Mon, Aug 07, 2023 · 8:30 AM ET | Replay |
| Quantum-Si (NASDAQ:QSI) Q1 2023 Earnings Call | Thu, May 11, 2023 · 4:30 PM ET | Replay |
| Quantum-Si (NASDAQ:QSI) Q4 2022 Earnings Call | Mon, Mar 06, 2023 · 8:30 AM ET | Replay |
| Quantum-Si (NASDAQ:QSI) Q3 2022 Earnings Call | Mon, Nov 07, 2022 · 4:30 PM ET | Replay |
| Quantum-Si (NASDAQ:QSI) Q2 2022 Earnings Call | Mon, Aug 08, 2022 · 4:30 PM ET | Replay |
| Quantum-Si (NASDAQ:QSI) Q1 2022 Earnings Call | Mon, May 09, 2022 · 4:30 PM ET | Replay |
| Quantum-Si (NASDAQ:QSI) Q4 2021 Earnings Call | Mon, Feb 28, 2022 · 4:30 PM ET | Replay |
| Quantum-Si (NASDAQ:QSI) Q3 2021 Earnings Call | Thu, Nov 11, 2021 · 8:30 AM ET | Replay |
| Quantum-Si (NASDAQ:QSI) Q2 2021 Earnings Call | Mon, Aug 16, 2021 · 4:30 PM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 5, 2026 · After close | +13.7% |
| Q2 2026 | Aug 13, 2026 · After close | −6.3% |
| Q1 2026 | May 7, 2026 · After close | −7.5% |
| Q4 2025 | Mar 3, 2026 | −2.5% |
| Q3 2025 | Nov 5, 2025 · After close | −8.3% |
| Q2 2025 | Aug 5, 2025 · After close | −4.9% |
| Q1 2025 | May 15, 2025 · After close | 0.0% |
| Q4 2024 | Feb 26, 2025 · After close | −9.4% |
| Q3 2024 | Nov 12, 2024 · Before open | −22.4% |
| Q2 2024 | Aug 7, 2024 · After close | +3.4% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 9, 2024 · After close | −7.1% |
| Q4 2023 | Feb 29, 2024 · After close | +10.8% |
| Q3 2023 | Nov 9, 2023 · After close | +6.8% |
| Q2 2023 | Aug 7, 2023 · Before open | −32.1% |
| Q1 2023 | May 11, 2023 · After close | −8.4% |
| Q4 2022 | Mar 6, 2023 · Before open | −13.0% |
| Q3 2022 | Nov 7, 2022 · After close | +2.0% |
| Q2 2022 | Aug 8, 2022 · After close | −9.3% |
| Q1 2022 | May 9, 2022 · After close | −3.4% |
| Q4 2021 | Feb 28, 2022 · After close | +13.5% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| World HUPO 2026 | Conference | 21 slides | Sep 29, 2026 |
| Investor Presentation (December 2025) | Investor deck | 23 slides | Dec 29, 2025 |
| Investor Day (November 2025) | Investor day | 79 slides | Nov 20, 2025 |
| Investor Day (November 2025) | Investor day | 79 slides | Nov 19, 2025 |
| Investor Presentation (August 2025) | Investor deck | 26 slides | Aug 8, 2025 |
| Investor Presentation (April 2025) | Investor deck | 28 slides | Apr 10, 2025 |
| Investor Day (November 2024) | Investor day | 78 slides | Nov 21, 2024 |
| Investor Presentation (August 2024) | Investor deck | 24 slides | Aug 13, 2024 |
| Investor Presentation (June 2024) | Investor deck | 23 slides | Jun 25, 2024 |
| Investor Presentation (April 2024) | Investor deck | 23 slides | Apr 9, 2024 |
All 14 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (March 2022) | Investor deck | 27 slides | Mar 8, 2022 |
| Investor Presentation (September 2021) | Investor deck | 17 slides | Sep 29, 2021 |
| Investor Presentation (June 2021) | Investor deck | 16 slides | Jun 15, 2021 |
| SPAC Merger (February 2021) | SPAC merger | 29 slides | Feb 18, 2021 |
Financings
| Raise | Date |
|---|---|
| Registered direct offering of shares of common stock (and common stock equivalents) Announced: about US$50M · US$1.67 a share · A.G.P./Alliance Global Partners Dealers: A.G.P./Alliance Global Partners (lead) Use of proceeds: Working capital and general corporate purposes | Jul 4, 2025 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Went public as HighCape Capital Acquisition Corp., a blank check company (SPAC). Priced at US$10.00 a unit on Sep 3, 2020.
- Price
- US$10.00 a unit
- Units offered
- 10,000,000 units
- Offering size
- US$100 million
- Underwriters' option
- Up to 1,500,000 more units
- Listing
- CAPAU on the Nasdaq Capital Market
- Underwriter
- Cantor
- Units delivered
- On or about Sep 9, 2020
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jul 2, 2020 |
| Filed publicly | Aug 3, 2020 |
| Amended twice | Newest Aug 31, 2020 |
| Shares registered with an exchange | Sep 2, 2020 |
| Declared effective by the SEC | Sep 3, 2020 |
| Final prospectus, with the price | Sep 4, 2020 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Sep 4, 2020 |
| EFFECT · Notice that a registration is effective | Sep 3, 2020 |
| CERT · Exchange's certificate of listing | Sep 3, 2020 |
| 8-A12B · Registration of shares for listing on an exchange | Sep 2, 2020 |
| CORRESP · Letter to the SEC | Sep 1, 2020 |
| CORRESP · Letter to the SEC | Sep 1, 2020 |
| CORRESP · Letter to the SEC | Aug 31, 2020 |
| S-1/A · Registration statement, amended | Aug 31, 2020 |
| UPLOAD · Letter from the SEC | Aug 18, 2020 |
| S-1/A · Registration statement, amended | Aug 10, 2020 |
All 12 filings
| Filing | Filed |
|---|---|
| S-1 · Registration statement | Aug 3, 2020 |
| DRS · Draft registration statement | Jul 2, 2020 |
Open IPO · From the cover of the final prospectus (424B4) filed Sep 4, 2020
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 2.44M | 3.06M | 1.08M | 0 | 0 | 0 | 0 |
| Cost of revenue | 1.28M | 1.46M | 594.0K | 0 | 0 | 894.0K | |
| Gross profit | 1.15M | 1.60M | 488.0K | 0 | 0 | -894.0K | |
| Research and development | 53.8M | 59.6M | 67.0M | 72.1M | 46.6M | 27.6M | 28.1M |
| Selling, general and administrative | 44.8M | 50.5M | 44.6M | 42.3M | 50.3M | 9.14M | 7.88M |
| Operating income | -116.1M | -108.6M | -111.2M | -123.8M | -96.9M | -36.7M | -36.6M |
| Depreciation and amortization | 4.45M | 4.60M | 4.16M | 2.58M | 1.04M | 894.0K | 780.0K |
| EBITDA | -111.6M | -104.0M | -107.0M | -121.3M | -95.9M | -35.8M | -35.8M |
| Interest expense | 0 | 0 | 5.00K | 9.00K | 0 | ||
| Income before tax | -101.3M | -101.0M | -96.0M | -132.4M | -95.0M | -36.6M | -35.8M |
| Income tax | 58.0K | 56.0K | 0 | 0 | 0 | 0 | 0 |
| Net income | -101.3M | -101.0M | -96.0M | -132.4M | -95.0M | -36.6M | -35.8M |
| Earnings per share, basic | -0.51 | -0.71 | -0.68 | -0.95 | -1.19 | -6.84 | -6.95 |
| Earnings per share, diluted | -0.51 | -0.71 | -0.68 | -0.95 | -1.19 | -6.84 | -6.95 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 21.6M | 49.2M | 133.9M | 84.3M | 35.8M | 36.9M | 32.9M |
| Short-term investments | 141.3M | 160.4M | 123.9M | 267.0M | 435.5M | 0 | |
| Receivables | 561.0K | 1.33M | 368.0K | 0 | 872.0K | 550.0K | 826.0K |
| Inventory | 3.20M | 4.07M | 3.94M | 0 | -872.0K | ||
| Current assets | 175.9M | 218.0M | 266.3M | 358.2M | 477.2M | 37.9M | 33.9M |
| Property, plant and equipment | 13.2M | 16.0M | 16.3M | 16.8M | 8.91M | 2.00M | 2.55M |
| Goodwill | 0 | 9.48M | 0 | ||||
| Total assets | 245.6M | 247.9M | 298.3M | 391.5M | 503.2M | 40.6M | 37.4M |
| Accounts payable | 1.62M | 1.93M | 1.77M | 3.90M | 3.39M | 1.33M | 869.0K |
| Current liabilities | 23.0M | 18.2M | 11.6M | 15.7M | 11.5M | 2.75M | 1.93M |
| Long-term debt | 1.75M | ||||||
| Total debt | 4.17M | 12.9M | 15.3M | 17.4M | 8.08M | 1.75M | |
| Total liabilities | 25.4M | 32.5M | 26.6M | 32.8M | 26.2M | 4.50M | 1.93M |
| Shareholders' equity | 220.2M | 215.4M | 271.6M | 358.7M | 477.0M | -159.7M | -125.1M |
| Shares outstanding | 197.8M | 143.2M | 141.3M | 139.3M | 79.6M | 5.38M | 136.4M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -94.7M | -87.8M | -94.0M | -90.6M | -66.8M | -32.6M | -30.7M |
| Capital spending | -2.52M | -4.58M | -4.51M | -10.7M | -5.76M | -461.0K | -1.24M |
| Free cash flow | -97.2M | -92.4M | -98.5M | -101.3M | -72.6M | -33.0M | -31.9M |
| Cash from investing | -28.3M | -32.7M | 143.4M | 137.2M | -450.9M | -461.0K | -1.24M |
| Cash from financing | 95.4M | 35.9M | 149.0K | 1.91M | 516.6M | 37.0M | 18.2M |
| Share buybacks | 2.76M | 5.61M | 116.8M | ||||
| Change in cash | -27.6M | -84.6M | 49.5M | 48.5M | -1.13M | 3.98M | -13.7M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Nov 18, 2026 | Current report | SEC |
| 10-Q · Quarterly report | Nov 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 5, 2026 | Results | SEC |
| 8-K · Current report | Oct 15, 2026 | Current report | SEC |
| 8-K · Current report | Oct 8, 2026 | Current report | SEC |
| 8-K · Current report | Sep 28, 2026 | Current report | SEC |
| 4 · Change in ownership | Sep 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 23, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 23, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 23, 2026 | Other filings | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 144 · Notice of proposed sale | Sep 23, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 23, 2026 | Other filings | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Aug 28, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Aug 13, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 13, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 29, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Jul 24, 2026 | Current report | SEC |
| 4 · Change in ownership | Jun 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 24, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 24, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 24, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 24, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 24, 2026 | Other filings | SEC |
| 8-K · Current report | Jun 24, 2026 | Material contract | SEC |
| 25-NSE | Jun 10, 2026 | Other filings | SEC |
| SD · Specialized disclosure | May 22, 2026 | ESG report | SEC |
| 4 · Change in ownership | May 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2026 | Insider trade | SEC |
| 8-K · Current report | May 15, 2026 | Meeting outcome | SEC |
| 10-Q · Quarterly report | May 7, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 7, 2026 | Results | SEC |
| 4 · Change in ownership | Apr 22, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 22, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Apr 22, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Apr 22, 2026 | Other filings | SEC |
| ARS · Annual report to shareholders | Apr 1, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 1, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 1, 2026 | Meeting notice | SEC |
| 4 · Change in ownership | Mar 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 24, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 24, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 24, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 24, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Mar 24, 2026 | Other filings | SEC |
| 4 · Change in ownership | Mar 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Mar 3, 2026 | Offer document | SEC |
| 10-K · Annual report | Mar 3, 2026 | Annual report | SEC |
| 8-K · Current report | Mar 3, 2026 | Results | SEC |
| 4 · Change in ownership | Feb 26, 2026 | Insider trade | SEC |
| 8-K · Current report | Dec 29, 2025 | Current report | SEC |
| 4 · Change in ownership | Dec 22, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 22, 2025 | Other filings | SEC |
| 4 · Change in ownership | Dec 22, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 22, 2025 | Other filings | SEC |
| 4 · Change in ownership | Dec 22, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 22, 2025 | Other filings | SEC |
| 4 · Change in ownership | Dec 22, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 22, 2025 | Other filings | SEC |
| 8-K · Current report | Nov 20, 2025 | Current report | SEC |
| 10-Q · Quarterly report | Nov 5, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 5, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 30, 2025 | Big-stake notice | SEC |
| 424B3 · Prospectus | Oct 29, 2025 | Offer document | SEC |
| 144 · Notice of proposed sale | Oct 20, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 20, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 20, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 20, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 20, 2025 | Other filings | SEC |
| 4 · Change in ownership | Oct 17, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 16, 2025 | Other filings | SEC |
| S-3/A · Registration statement, amended | Oct 9, 2025 | Offer document | SEC |
| 8-K · Current report | Sep 29, 2025 | Material contract | SEC |
| S-3 · Registration statement | Sep 26, 2025 | Offer document | SEC |
| 8-K · Current report | Sep 26, 2025 | Material contract | SEC |
| 4 · Change in ownership | Sep 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 24, 2025 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Sep 11, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Aug 8, 2025 | Current report | SEC |
| 10-Q · Quarterly report | Aug 5, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 5, 2025 | Results | SEC |
| SCHEDULE 13G · Big-stake notice | Jul 29, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Jul 7, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Jul 7, 2025 | Offer document | SEC |
| 424B5 · Prospectus | Jul 7, 2025 | Offer document | SEC |
| 4 · Change in ownership | Jun 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 24, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jun 6, 2025 | Big-stake notice | SEC |
| SD · Specialized disclosure | May 22, 2025 | ESG report | SEC |
| 4 · Change in ownership | May 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2025 | Insider trade | SEC |
| 8-K · Current report | May 19, 2025 | Meeting outcome | SEC |
| 10-Q · Quarterly report | May 15, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 15, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 14, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Apr 10, 2025 | Current report | SEC |
| 4 · Change in ownership | Mar 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 24, 2025 | Insider trade | SEC |
| ARS · Annual report to shareholders | Mar 20, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Mar 20, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Mar 20, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Mar 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 14, 2025 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Mar 3, 2025 | Offer document | SEC |
| 10-K · Annual report | Mar 3, 2025 | Annual report | SEC |
| 8-K · Current report | Mar 3, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 13, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 4, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jan 10, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Jan 6, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Jan 6, 2025 | Offer document | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Dec 31, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Dec 31, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 27, 2024 | Other filings | SEC |
| 4 · Change in ownership | Dec 26, 2024 | Insider trade | SEC |
| 8-K · Current report | Dec 11, 2024 | Material contract | SEC |
| 424B5 · Prospectus | Dec 11, 2024 | Offer document | SEC |
| 8-K · Current report | Dec 9, 2024 | Current report | SEC |
| 8-K · Current report | Nov 22, 2024 | Current report | SEC |
| 8-K · Current report | Nov 20, 2024 | Current report | SEC |
| 10-Q · Quarterly report | Nov 12, 2024 | Quarterly report | SEC |
| 8-K/A · Current report, amended | Nov 12, 2024 | Current report | SEC |
| 8-K · Current report | Nov 12, 2024 | Results | SEC |
| 8-K · Current report | Nov 8, 2024 | Current report | SEC |
| 4 · Change in ownership | Sep 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 18, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 18, 2024 | Insider trade | SEC |
| SC 13D/A · Big-stake notice, amended | Sep 17, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Aug 27, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Aug 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 13, 2024 | Insider trade | SEC |
| 8-K · Current report | Aug 12, 2024 | Current report | SEC |
| 3 · Initial statement of ownership | Aug 12, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 7, 2024 | Quarterly report | SEC |
| 8-K · Current report | Aug 7, 2024 | Results | SEC |
| SC 13G/A · Big-stake notice, amended | Jun 28, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Jun 25, 2024 | Insider trade | SEC |
| 8-K · Current report | Jun 25, 2024 | Current report | SEC |
| 144 · Notice of proposed sale | Jun 21, 2024 | Other filings | SEC |
| 4 · Change in ownership | Jun 7, 2024 | Insider trade | SEC |
| 8-K · Current report | Jun 7, 2024 | Current report | SEC |
| 4 · Change in ownership | May 30, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 30, 2024 | Insider trade | SEC |
| 8-K · Current report | May 30, 2024 | Management or board change | SEC |
| 144 · Notice of proposed sale | May 24, 2024 | Other filings | SEC |
| 8-K · Current report | May 24, 2024 | Current report | SEC |
| 4 · Change in ownership | May 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 17, 2024 | Insider trade | SEC |
| 8-K · Current report | May 17, 2024 | Meeting outcome | SEC |
| 10-Q · Quarterly report | May 9, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 9, 2024 | Results | SEC |
| DEFR14A | Apr 29, 2024 | Meeting notice | SEC |
| 8-K · Current report | Apr 9, 2024 | Current report | SEC |
| ARS · Annual report to shareholders | Apr 1, 2024 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 1, 2024 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 1, 2024 | Meeting notice | SEC |
| 4 · Change in ownership | Mar 25, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 25, 2024 | Insider trade | SEC |
| PRE 14A · Preliminary proxy statement | Mar 22, 2024 | Meeting notice | SEC |
This page holds 200 of 474 filings. Open Filings
Cap table
Built by 6ix from Quantum-Si Incorporated’s releases · as of Nov 13, 2026
- Common shares
- 198,946,412
- Fully diluted
- 199,441,747
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 198,946,412 | |
| Options and RSUs | 495,335 | Nov 13, 2026 |
Warrants and options
| Lot |
|---|
| RSUs · expiry not stated |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 198,946,412 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Marijn E Dekkers Other companies: Ginkgo Bioworks Holdings, Inc. (Director · Sep 16, 2021 – Jun 12, 2024 · Past); Cerevel Therapeutics Holdings Inc (Director · Oct 27, 2020 – Aug 1, 2024 · Past); Quanterix Corporation (Director · Dec 6, 2017 – Jan 11, 2021 · Past); GE Aerospace (Director · Jun 12, 2012 – Apr 2, 2018 · Past); Biogen Inc. (Director · May 31, 2007 – Jun 3, 2009 · Past); Thermo Fisher Scientific Inc (Chief Executive Officer, Director · Jan 7, 2006 – Aug 17, 2009 · Past) | Director · Jun 10, 2021 – May 11, 2022 · Past |
| Brigid A. Makes Other companies: Elutia, Inc. (Board Member · Since at least Oct 7, 2020); Vivani Medical, Inc. (Chief Financial Officer · Aug 30, 2022 – May 12, 2025 · Past); Definium Therapeutics, Inc. (Director · Jan 1, 2022 – Jun 1, 2022 · Past); AGA Medical Holdings Inc (CFO · Oct 20, 2009 – Nov 18, 2010 · Past); Bioject Medical Technologies Inc (Director · Sep 14, 2006 – Jun 5, 2009 · Past) | Director · Since at least Jun 10, 2021 |
| Jim Tananbaum Other companies: Latigo Biotherapeutics, Inc. (Director · Since at least Aug 6, 2026); Alumis Inc. (Director · Since at least Jun 27, 2024); Pardes Biosciences Inc (President and CEO, Director · Feb 16, 2021 – Aug 31, 2023 · Past); Kinnate Biopharma Inc (Director · Dec 2, 2020 – Apr 3, 2024 · Past); Disc Medicine, Inc. (Director · Aug 11, 2020 – Oct 4, 2021 · Past) | Director · Jun 10, 2021 – Jun 10, 2021 · Past |
| Charles Kummeth Other companies: Orthofix Medical Inc. (Director · Since at least Dec 14, 2023); Gentherm Inc (Member of the Board · Since at least Aug 1, 2018); Bio-Techne Corp (Chief Executive Officer, Director · Apr 1, 2013 – Aug 15, 2023 · Past); Sparton Corporation (Director · Nov 11, 2011 – Mar 4, 2019 · Past) | Chairman of the Board · Since at least May 27, 2024 |
| Jack Kenny Other companies: NeoGenomics, Inc. (Director · Since at least Jan 1, 2026); OraSure Technologies, Inc. (Director · Since at least Sep 6, 2024); Biomerica, Inc. (Director · Aug 28, 2023 – Dec 13, 2023 · Past); Meridian Bioscience Inc (Chief Executive Officer, Director · Oct 9, 2017 – Jan 31, 2023 · Past) | Director · Since at least May 19, 2023 |
| Scott Mendel Other companies: Quanterix Corporation (Director · Since at least Jul 8, 2025); Akoya Biosciences Inc (Director · Since at least Jun 11, 2021); GenMark Diagnostics Inc (President & CEO, Director · May 13, 2014 – Apr 22, 2021 · Past); Active Network Inc (Chief Financial Officer · May 24, 2011 – Nov 15, 2013 · Past) | Director · Since at least May 11, 2023 |
| Claudia N. Drayton Other companies: Brookdale Senior Living Inc. (Director · Since at least Jun 18, 2024); 3D Systems Corporation (Director · Since at least Dec 1, 2021); Nuwellis, Inc. (Chief Financial Officer · Jan 5, 2015 – Jan 22, 2021 · Past) | Chief Financial Officer · Jun 10, 2021 – Mar 15, 2023 · Past |
| Kevin Rakin Other companies: Elutia, Inc. (Chairman · Since at least Oct 7, 2020); Oramed Pharmaceuticals Inc. (Director · Aug 30, 2016 – Mar 21, 2022 · Past); Ocugen, Inc. (Director · Dec 2, 2014 – Feb 8, 2019 · Past) | Director · Since at least Sep 3, 2020 |
| Matthew Zuga Other companies: Acumen Pharmaceuticals, Inc. (Chief Financial Officer & Chief Business Officer · Since at least Jun 30, 2021); Elutia, Inc. (Director · Since at least Oct 7, 2020); TELA Bio, Inc. (Director · Nov 7, 2019 – Nov 8, 2019 · Past) | Director · Sep 3, 2020 – Sep 3, 2020 · Past |
| Jonathan Rothberg Other companies: Hyperfine, Inc. (Director · Since at least Dec 22, 2021); Butterfly Network, Inc. (Director · Since at least Feb 12, 2021) | Director · Since at least Jun 10, 2021 |
All 33 people
| Person | Seat |
|---|---|
| Ruth Fattori Other companies: Hyperfine, Inc. (Director · Since at least Dec 22, 2021); PepsiCo, Inc. (EVP, HR & Chief HR Officer · Oct 1, 2017 – Mar 1, 2018 · Past) | Director · Since at least Jun 10, 2021 |
| Antony Loebel Other companies: Seaport Therapeutics, Inc. (Chief Medical Officer and President of Clinical Development · Since at least Apr 30, 2026) | Director · Sep 3, 2020 – Sep 3, 2020 · Past |
| David Colpman Other companies: Elutia, Inc. (Board Member · Since at least Oct 20, 2022) | Director · Sep 3, 2020 – Sep 3, 2020 · Past |
| Jeffrey Alan Hawkins Other companies: GenMark Diagnostics Inc (SVP, Global Marketing & PM · Nov 3, 2010 – Sep 11, 2015 · Past) | President & CEO, Director · Since at least Oct 10, 2022 |
| Jeffry R. Keyes Other companies: CNS Pharmaceuticals, Inc. (Director · Since at least Nov 7, 2019) | Chief Financial Officer · Since at least May 15, 2023 |
| Michael Mina Other companies: Invivyd, Inc. (Chief Medical Officer and Chief Epidemiologist · Since Mar 5, 2026) | Director · Jun 10, 2021 – May 12, 2023 · Past |
| Robert Taub Other companies: Omrix Biopharmaceuticals Inc (Chief Executive Officer, Director · Apr 11, 2006 – Nov 23, 2008 · Past) | Director · Sep 3, 2020 – Sep 3, 2020 · Past |
| Vikram Bajaj Other companies: Disc Medicine, Inc. (Director · Aug 11, 2020 – Aug 11, 2020 · Past) | Director · Jun 15, 2022 – Jun 16, 2022 · Past |
| Amir Jafri | Director · Since at least Sep 22, 2023 |
| Beth Peralta | Vice President, Human Resources · Since at least Nov 4, 2026 |
| Christian LaPointe | GC & Corp. Secretary · Since at least Jun 10, 2021 |
| Gloria Sheynkman | Chair, Scientific Advisory Board · Since at least Apr 15, 2026 |
| Grace Johnston | Chief Commercial Officer · Dec 21, 2022 – Jun 21, 2024 · Past |
| Jeff Hawkins | President and Chief Executive Officer · Since at least Sep 23, 2026 |
| Jeff Keyes | Chief Financial Officer · Since at least Oct 16, 2026 |
| John S Vieceli | Chief Product Officer · Since at least Aug 2, 2024 |
| John VIII Stark | Chief Executive Officer, Director · Jun 10, 2021 – Jan 10, 2022 · Past |
| Matthew Dyer | Chief Business Officer · Jun 10, 2021 – Jun 13, 2022 · Past |
| Michael P McKenna | EVP, Product Development & Ops · Jun 10, 2021 – Mar 15, 2023 · Past |
| Patrick Schneider | President and COO · May 9, 2022 – Mar 15, 2023 · Past |
| Paula Dowdy | Director · Since at least Mar 21, 2024 |
| Ryan Miranovich | Vice President, Legal · Since at least Nov 5, 2026 |
| Todd C Bennett | Chief Commercial Officer · Since at least Sep 17, 2024 |
Log in to ask 6ix AI your own questions about Quantum-Si Incorporated.